Moreover, besides VEGF, ADAM10 mRNA is also a target of PKC/nELAV pathway [216] and Aβ was shown to impair ADAM10 expression both in vitro and in AD hippocampi [215]. Here, PRRT2 is linked to Alzheimer disease.